XML 63 R46.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Stock-Based Compensation Expense
Total stock-based compensation expense included in our Consolidated Statements of Operations was as follows: 
 
 
Year Ended
(In thousands)
 
December 31, 2016
 
January 2, 2016
 
January 3, 2015
Cost of products sold
 
$
888

 
$
1,416

 
$
819

Research and development
 
7,928

 
9,141

 
5,176

Selling, general, and administrative
 
7,397

 
6,793

 
6,807

Acquisition related charges
 

 
4,293

 

Total stock-based compensation
 
$
16,213

 
$
21,643

 
$
12,802

Schedule of Share-based Payment Award, Stock Options and Employee Stock Purchase Plan, Valuation Assumptions
The following table summarizes the assumptions used in the valuation of stock option and ESPP compensation for fiscal years 2016, 2015, and 2014:
 
Year Ended
 
December 31, 2016
 
January 2, 2016
 
January 3, 2015
Employee and Director Stock Options
 
 
 
 
 
Expected volatility
44.2% to 50.8%
 
43.6% to 47.3%
 
45.4% to 50.4%
Risk-free interest rate
.94% - 2.06%
 
1.4% to 1.7%
 
1.5% to 1.7%
Expected term (years)
4.06 - 4.78
 
4.08 to 4.75
 
4.1 to 4.7
Dividend yield
—%
 
—%
 
—%
Employee Stock Purchase Plan
 
 
 
 
 
Weighted average expected volatility
57.9%
 
33.6%
 
38.7%
Weighted average risk-free interest rate
0.43%
 
0.12%
 
0.08%
Expected term
6 months
 
6 months
 
6 months
Dividend yield
—%
 
—%
 
—%
Schedule of Share-based Compensation, Stock Options, Activity
The following table summarizes our stock option activity and related information for the year ended December 31, 2016:
(Shares and aggregate intrinsic value in thousands)
Shares
 
Weighted
average
exercise price
 
Weighted average
remaining
contractual term (years)
 
Aggregate
Intrinsic Value
Balance, January 2, 2016
11,444

 
$
5.46

 
 
 
 
Granted
3,907

 
5.65

 
 
 
 
Exercised
(1,466
)
 
3.91

 
 
 
 
Forfeited or expired
(1,319
)
 
5.47

 
 
 
 
Balance, December 31, 2016
12,566

 
$
5.70

 
 
 
 
Vested and expected to vest at December 31, 2016
12,566

 
$
5.70

 
4.39
 
$
20,966

Exercisable, December 31, 2016
6,876

 
$
5.65

 
3.15
 
$
11,851

Schedule of Nonvested Restricted Stock Units Activity
The following table summarizes our RSU activity for the year ended December 31, 2016:
(Shares in thousands)
Shares
 
Weighted average grant date fair value
Balance, January 2, 2016
4,757

 
$
5.95

Granted
1,376

 
5.64

Exercised
(1,742
)
 
5.97

Forfeited or expired
(1,144
)
 
5.68

Balance, December 31, 2016
3,247

 
$
5.90

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The following table summarizes the assumptions used in the valuation of stock options and RSUs with a market condition for fiscal years 2016, 2015 and 2014:
 
Year Ended
 
December 31, 2016
 
January 2, 2016
 
January 3, 2015
Executive stock options with a market condition
 
 
 
 
 
Expected volatility
46%
 
44% to 46%
 
n/a
Risk-free interest rate
1.1%
 
1.4%
 
n/a
Expected term (years)
4.5
 
4.5
 
n/a
Dividend yield
—%
 
—%
 
n/a
Executive RSUs with a market condition
 
 
 
 
 
Expected volatility
n/a
 
36.9%
 
53.5%
Risk-free interest rate
n/a
 
0.6%
 
2.2%
Expected term (years)
n/a
 
2.0
 
0.2
Dividend yield
n/a
 
—%
 
—%